Feasibility of Intravenous Iron Isomaltoside to Improve Anemia and Quality of Life During Palliative Chemotherapy for Esophagogastric Adenocarcinoma

Background: Anemia is common with esophagogastric adenocarcinoma, increasing mortality, blood transfusions, and reducing quality of life (QOL). No clear evidence exists for safe and effective treatment. Methods: Anemic patients (Hb

Saved in:
Bibliographic Details
Published in:Nutrition and cancer 2018-10, Vol.70 (7), p.1106-1117
Main Authors: Ng, Oliver, Keeler, Barrie, Simpson, John Alastair, Madhusudan, Srinivasan, Brookes, Matthew, Acheson, Austin
Format: Article
Language:English
Subjects:
Adenocarcinoma
Anemia
Blood transfusion
Blood transfusions
Chemotherapy
Feasibility studies
Ferritin
Hemoglobin
Intravenous administration
Iron
Palliation
Patients
Quality of life
Randomization
Transferrin
Transferrins
Transfusion
Well being
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background: Anemia is common with esophagogastric adenocarcinoma, increasing mortality, blood transfusions, and reducing quality of life (QOL). No clear evidence exists for safe and effective treatment. Methods: Anemic patients (Hb
ISSN:0163-5581
1532-7914
DOI:10.1080/01635581.2018.1504090